0R15 8520.0 0.0% 0R1E 8203.0 0.0% 0M69 21090.0 67.5139% 0R2V 226.02 9878.8079% 0QYR None None% 0QYP 412.97 -2.8306% 0RUK 2652.0 -9.2402% 0RYA 1554.0 -0.7029% 0RIH 174.55 -1.3563% 0RIH 165.15 -5.3853% 0R1O 198.5 9800.2494% 0R1O None None% 0QFP None None% 0M2Z 267.777 -0.1763% 0VSO 32.05 -9.9846% 0R1I None None% 0QZI 559.0 0.7207% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 165.7358 2.7149%
Last update at 2024-11-20T20:00:00Z
Lifeway (LWAY) Stock Jumps 23.6%: Will It Continue to Soar?
Wed 25 Sep 24, 12:01 PMFood companies Ajinomoto and Danone launch partnership to cut dairy industry's CO2 emissions
Thu 19 Sep 24, 12:45 PMJefferies downgrades Danone amid risk of slowdown in 3 key segments
Fri 13 Sep 24, 10:43 AMLifeway Foods Inc (LWAY) Stock: A Bull Case Theory
Fri 06 Sep 24, 02:13 PMAre You Looking for a Top Momentum Pick? Why Danone (DANOY) is a Great Choice
Thu 05 Sep 24, 04:00 PMAre Consumer Staples Stocks Lagging Danone (DANOY) This Year?
Thu 05 Sep 24, 01:40 PMDanone Backs Guidance as Shoppers Welcome Easing Price Hikes
Wed 31 Jul 24, 09:28 AMDanone: Notification of availability of Danone’s 2024 interim financial repor
Wed 31 Jul 24, 06:04 AMDanone: Strong half-year results; Delivering broad-based quality growth
Wed 31 Jul 24, 05:31 AMDanone acquires Functional Formularies
Wed 01 May 24, 06:00 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 1832.00M | 1995.00M | 2488.00M | 2867.00M | 2393.00M |
| Minority interest | -64.00000M | -67.00000M | 93.00M | 137.00M | 131.00M |
| Net income | 959.00M | 1924.00M | 1956.00M | 1929.00M | 2349.00M |
| Selling general administrative | 8931.00M | 7843.00M | 7651.00M | 8158.00M | 7860.00M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 12739.00M | 11521.00M | 11353.00M | 12409.00M | 11922.00M |
| Reconciled depreciation | 1863.00M | 1265.00M | 1452.00M | 1386.00M | 1601.00M |
| Ebit | 3383.00M | 3335.00M | 3329.00M | 3868.00M | 3623.00M |
| Ebitda | 4003.00M | 3583.00M | 4298.00M | 4653.00M | 4387.00M |
| Depreciation and amortization | - | - | - | - | - |
| Non operating income net other | - | - | - | - | 0.00000M |
| Operating income | 3416.00M | 3301.00M | 3335.00M | 3805.00M | 2697.00M |
| Other operating expenses | 86.00M | 5.00M | 50.00M | 32.00M | 66.00M |
| Interest expense | 308.00M | 323.00M | 358.00M | 400.00M | 393.00M |
| Tax provision | 778.00M | 589.00M | 762.00M | 793.00M | 716.00M |
| Interest income | 155.00M | 156.00M | 151.00M | 181.00M | 162.00M |
| Net interest income | -310.00000M | -262.00000M | -310.00000M | -370.00000M | -348.00000M |
| Extraordinary items | - | - | - | - | 0.00000M |
| Non recurring | - | - | - | - | 0.00000M |
| Other items | - | - | - | - | 0.00000M |
| Income tax expense | 778.00M | 589.00M | 762.00M | 793.00M | 716.00M |
| Total revenue | 27661.00M | 24281.00M | 23620.00M | 25287.00M | 24651.00M |
| Total operating expenses | 24245.00M | 20980.00M | 20285.00M | 21482.00M | 21954.00M |
| Cost of revenue | 14922.00M | 12760.00M | 12267.00M | 12878.00M | 12729.00M |
| Total other income expense net | - | - | - | -1175.00000M | -468.00000M |
| Discontinued operations | - | - | - | - | 0.00000M |
| Net income from continuing ops | 1022.00M | 1991.00M | 2030.00M | 2028.00M | 2439.00M |
| Net income applicable to common shares | 946.00M | 1898.00M | 1941.00M | 1915.00M | 2335.00M |
| Preferred stock and other adjustments | - | - | - | - | 0.00000M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 45281.00M | 45420.00M | 42776.00M | 45362.00M | 44177.00M |
| Intangible assets | 6302.00M | 6182.00M | 6020.00M | 6677.00M | 6735.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | 710.00M | 602.00M | 1163.00M | 186.00M | 180.00M |
| Total liab | 27289.00M | 28045.00M | 26478.00M | 27984.00M | 27702.00M |
| Total stockholder equity | 17923.00M | 17273.00M | 16205.00M | 17241.00M | 16344.00M |
| Deferred long term liab | - | - | - | - | 0.00000M |
| Other current liab | 567.00M | 413.00M | 397.00M | 331.00M | 375.00M |
| Common stock | 169.00M | 172.00M | 172.00M | 172.00M | 171.00M |
| Capital stock | 169.00M | 172.00M | 172.00M | 172.00M | 171.00M |
| Retained earnings | 16666.00M | 18038.00M | 17374.00M | 16491.00M | 15896.00M |
| Other liab | 3921.00M | 4430.00M | 3798.00M | 3824.00M | 3393.00M |
| Good will | 17938.00M | 17871.00M | 17016.00M | 18125.00M | 17711.00M |
| Other assets | 767.00M | 1139.00M | 1170.00M | 1186.00M | 955.00M |
| Cash | 1051.00M | 659.00M | 593.00M | 644.00M | 839.00M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 12130.00M | 11078.00M | 10338.00M | 11253.00M | 9965.00M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | 12180.00M | 14568.00M | 14476.00M | 15224.00M | 15654.00M |
| Short term debt | - | - | - | 3781.00M | 0.00000M |
| Short long term debt | 3155.00M | 3552.00M | 3540.00M | 3781.00M | 2564.00M |
| Short long term debt total | - | - | - | - | - |
| Other stockholder equity | -2531.00000M | -4491.00000M | -5635.00000M | -3671.00000M | -3896.00000M |
| Property plant equipment | 6752.00M | 6843.00M | 6572.00M | 6844.00M | 6175.00M |
| Total current assets | 12153.00M | 12056.00M | 10638.00M | 10118.00M | 10334.00M |
| Long term investments | - | - | - | 2412.00M | 2267.00M |
| Net tangible assets | -6316.00000M | -6780.00000M | -6831.00000M | -7561.00000M | -8102.00000M |
| Short term investments | 3631.00M | 5197.00M | 3680.00M | 3631.00M | 4199.00M |
| Net receivables | 4142.00M | 3616.00M | 3362.00M | 3724.00M | 3327.00M |
| Long term debt | 10076.00M | 11675.00M | 11529.00M | 12087.00M | 13929.00M |
| Inventory | 2619.00M | 1982.00M | 1840.00M | 1933.00M | 1789.00M |
| Accounts payable | 4899.00M | 3998.00M | 3467.00M | 3959.00M | 3675.00M |
| Total permanent equity | - | - | - | - | 0.00000M |
| Noncontrolling interest in consolidated entity | - | - | - | - | 0.00000M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | 0.00000M |
| Accumulated other comprehensive income | - | - | - | - | 0.00000M |
| Additional paid in capital | - | - | - | - | 0.00000M |
| Common stock total equity | - | - | - | - | 0.00000M |
| Preferred stock total equity | - | - | - | - | 0.00000M |
| Retained earnings total equity | - | - | - | - | 0.00000M |
| Treasury stock | - | - | - | - | 0.00000M |
| Accumulated amortization | - | - | - | - | 0.00000M |
| Non currrent assets other | -2.00000M | -1.00000M | 3.00M | 35244.00M | -2.00000M |
| Deferred long term asset charges | - | - | - | - | 0.00000M |
| Non current assets total | 33128.00M | 33364.00M | 32139.00M | 35244.00M | 33843.00M |
| Capital lease obligations | 933.00M | 982.00M | 966.00M | 1003.00M | 806.00M |
| Long term debt total | - | - | - | - | 0.00000M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -749.00000M | 1534.00M | 364.00M | -54.00000M | 1253.00M |
| Change to liabilities | 879.00M | 425.00M | -204.00000M | 266.00M | -770.00000M |
| Total cashflows from investing activities | -749.00000M | 561.00M | -610.00000M | -1008.00000M | 326.00M |
| Net borrowings | -2114.00000M | -345.00000M | -756.00000M | -1545.00000M | -1830.00000M |
| Total cash from financing activities | -1934.00000M | -4027.00000M | -2360.00000M | -2400.00000M | -3251.00000M |
| Change to operating activities | 289.00M | 239.00M | 239.00M | -131.00000M | 70.00M |
| Net income | 959.00M | 1924.00M | 1956.00M | 1929.00M | 2349.00M |
| Change in cash | 392.00M | 66.00M | -51.00000M | -195.00000M | 200.00M |
| Begin period cash flow | 659.00M | 593.00M | 644.00M | 839.00M | 638.00M |
| End period cash flow | 1051.00M | 659.00M | 593.00M | 644.00M | 839.00M |
| Total cash from operating activities | 2964.00M | 3474.00M | 2967.00M | 3444.00M | 3111.00M |
| Issuance of capital stock | 51.00M | 46.00M | 30.00M | 55.00M | 47.00M |
| Depreciation | 1087.00M | 1040.00M | 1089.00M | 1225.00M | 897.00M |
| Other cashflows from investing activities | - | - | -1.00000M | -1.00000M | 1.00M |
| Dividends paid | -1238.00000M | -1261.00000M | -1385.00000M | -1278.00000M | 445.00M |
| Change to inventory | -667.00000M | -81.00000M | -86.00000M | -178.00000M | -167.00000M |
| Change to account receivables | -424.00000M | -231.00000M | 59.00M | -268.00000M | 807.00M |
| Sale purchase of stock | 0.00000M | -801.00000M | 0.00000M | - | 0.00000M |
| Other cashflows from financing activities | 1367.00M | -1666.00000M | -249.00000M | 368.00M | -1023.00000M |
| Change to netincome | 841.00M | 158.00M | 153.00M | 601.00M | -75.00000M |
| Capital expenditures | 873.00M | 1043.00M | 962.00M | 951.00M | 941.00M |
| Change receivables | - | - | - | - | 0.00000M |
| Cash flows other operating | - | - | - | - | 0.00000M |
| Exchange rate changes | - | - | - | - | 0.00000M |
| Cash and cash equivalents changes | - | - | - | - | 0.00000M |
| Change in working capital | 77.00M | 352.00M | -231.00000M | -200.00000M | -47.00000M |
| Stock based compensation | 25.00M | 12.00M | 16.00M | 30.00M | - |
| Other non cash items | 46.00M | -1.00000M | 12.00M | 8.00M | 13.00M |
| Free cash flow | 2091.00M | 2431.00M | 2005.00M | 2493.00M | 2170.00M |
Sector: Consumer Defensive Industry: Packaged Foods
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| GPDNF Danone S.A |
- -% | 68.20 | 28.47 | 16.56 | 1.44 | 2.26 | 1.83 | 12.33 |
| NSRGF Nestle SA |
-0.92 1.06% | 85.68 | 26.86 | 18.76 | 3.13 | 7.10 | 3.81 | 21.70 |
| NSRGY Nestle SA ADR |
-1.21 1.39% | 85.66 | 26.82 | 18.66 | 3.18 | 7.07 | 3.81 | 21.70 |
| KHC Kraft Heinz Co |
0.17 0.55% | 31.05 | 15.59 | 11.79 | 1.64 | 0.88 | 2.34 | 11.32 |
| DANOY Danone PK |
-0.23 1.67% | 13.55 | 28.42 | 16.39 | 1.44 | 2.23 | 1.85 | 12.41 |
Danone S.A. operates in the food and beverage industry in Europe, North America, China, North Asia, the Oceania, Latin America, the Asia Pacific, Africa, the Middle East, and the Commonwealth of Independent States. The company operates through three segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. It produces and distributes yogurts; milk products; coffee creamers, beverages, and drinks; plant-based products; and ice creams, frozen desserts, and cheese products under the Actimel, Activia, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, Volvic, Danone, Prostokvashino, Light & Free, Oikos, Danissimo, YoPRO, International Delight, SToK, Silk, and So Delicious, as well as under the licensed brand Dunkin' Donuts. The company also provides specialized nutrition products for pregnant and breastfeeding mothers, infants, and young children under the Aptamil, Nutrilon, Gallia, Cow & Gate, Bebelac, Blédina, Olvarit, and Happy Family Organics brands. In addition, it offers tube feeding products under the Nutrison name; oral nutritional supplements under the Fortimel and NutriDrink names; and hypoallergenic products for children with allergies primarily under the Aptamil ProSyneo, Aptamil Pepti Syneo, and Neocate Syneo names. Further, the company provides water with natural fruit extracts, fruit juice, and vitamins under the evian, Volvic, Aqua, Mizone, Bonafont, Salus, Hayat, Sirma, Fontvella, Lanjarón, Zywiec Zdroj, Villavicencio, and Villa del Sur brands. It distributes its products through retail chains and traditional market outlets; convenience stores; hospitals, clinics, and pharmacies; and e-commerce. The company was formerly known as Groupe Danone and changed its name to Danone S.A. in April 2009. Danone S.A. was incorporated in 1899 and is headquartered in Paris, France.
17, Boulevard Haussmann, Paris, France, 75009
| Name | Title | Year Born |
|---|---|---|
| Mr. Antoine Bernard de Saint-Affrique | Director & CEO | 1964 |
| Ms. Véronique Penchienati-Bosetta | Chief Exec. Officer of International | 1967 |
| Mr. Shane Grant | Chief Exec. Officer of North America | NA |
| Mr. Juergen Esser | Chief Financial, Technology & Data Officer | 1972 |
| Mr. Vikram Agarwal | Chief Operations Officer & End-to-end Design To Delivery Coordinator | 1966 |
| Ms. Mathilde Rodie | Head of IR & Financial Communication | NA |
| Mr. Roberto Di Bernardini | Chief HR Officer | 1964 |
| Mr. Michel Alexandre David-Weill | Honorary Vice-Chairman | 1932 |
| Mr. Dominique Poiroux | Exec. VP of Advanced Medical Nutrition | NA |
| Mr. Henri Bruxelles | Chief Sustainability and Strategic Bus. Devel. Officer | 1965 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
UK 
AU
CA
US
NZ
Please wait processing your request...